Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diacerein for the treatment of epidermolysis bullosa simplex
DRKS00005412Phase 2Completed
- Sponsor
- EB House Austria
- Start
- Nov 2013
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of diacerein in epidermolysis bullosa simplex (EBS) (2 arms), sponsored by EB House Austria. Started Nov 2013; status: completed.
02
Drugs
diacerein
03
Conditions
epidermolysis bullosa simplex (EBS)
Beyond the preview
Go deeper on DRKS00005412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00005412.